Schedule 13G ownership disclosure

Dyne Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 26818M108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 0.00 · Class: 0.0%

  • Peter Kolchinsky

    Shares: 0.00 · Class: 0.0%

  • Rajeev Shah

    Shares: 0.00 · Class: 0.0%

  • RA Capital Healthcare Fund, L.P.

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-25-000487
Form type
SCHEDULE 13G/A
Filer
Dyne Therapeutics, Inc.
CIK
CIK 1818794
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub